Your shopping cart is currently empty

PDE2-IN-1 is a potent and orally active inhibitor of PDE2 with an IC50 of 0.6 μM, exhibiting neuroprotective properties. It regulates the PKA/CREB/BDNF signaling pathway by inhibiting PDE2. PDE2-IN-1 can improve memory deficits and cognitive impairments in okadai acid (OKA)-induced Alzheimer's disease (AD) mouse models and is useful for Alzheimer's disease research.
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | PDE2-IN-1 is a potent and orally active inhibitor of PDE2 with an IC50 of 0.6 μM, exhibiting neuroprotective properties. It regulates the PKA/CREB/BDNF signaling pathway by inhibiting PDE2. PDE2-IN-1 can improve memory deficits and cognitive impairments in okadai acid (OKA)-induced Alzheimer's disease (AD) mouse models and is useful for Alzheimer's disease research. |
| Targets&IC50 | PDE2:0.6 μM |
| In vitro | PDE2-IN-1 (compound 14c) (0-50 μM; 24 hours) exhibits no cytotoxic effects on neuron-like cells (U251, SY5Y, and HMC3). |
| In vivo | PDE2-IN-1, administered at doses of 10 and 30 mg/kg via intraperitoneal injection daily for 14 days, has been shown to improve memory deficits and cognitive impairment in an OKA-induced Alzheimer's disease (AD) mouse model. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.